Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

CinCor Pharma, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
02/28/2023 4 5AM Partners VI, LLC (10% Owner) has filed a Form 4 on CinCor Pharma, Inc.
Txns: Unknown transaction of 3,953,990 shares @ $0
Unknown transaction of 487,333 shares @ $0
Unknown transaction of 496,323 shares @ $0
02/27/2023 4 HEALY JAMES (10% Owner) has filed a Form 4 on CinCor Pharma, Inc.
Txns: Sold 6,000 shares @ $14.32, valued at $85.9k
Unknown transaction of 9,803 shares @ $0
Disposed/sold 19,608 shares @ $0
Unknown transaction of 6,073,949 shares @ $0
02/27/2023 4 Freeman Mason (Chief Medical Officer) has filed a Form 4 on CinCor Pharma, Inc.
Txns: Sold 6 shares @ $15.21, valued at $91.3
Unknown transaction of 2,494 shares @ $0
Disposed/sold 40,000 shares @ $0
Unknown transaction of 100 shares @ $0
Disposed/sold 30,178 options to buy @ $0.92, valued at $27.8k
Disposed/sold 145,296 options to buy @ $5.82, valued at $845.6k
Disposed/sold 120,380 options to buy @ $7.62, valued at $917.3k
02/24/2023 4 Allison David D. (Director) has filed a Form 4 on CinCor Pharma, Inc.
Txns: Disposed/sold 29,411 options to buy @ $13.6, valued at $400k
Disposed/sold 1,038 options to buy @ $19.55, valued at $20.3k
Disposed/sold 881 options to buy @ $20.2, valued at $17.8k
Disposed/sold 524 options to buy @ $33.49, valued at $17.5k
Disposed/sold 1,499 options to buy @ $11.78, valued at $17.7k
02/24/2023 4 Ignelzi Troy A. (Director) has filed a Form 4 on CinCor Pharma, Inc.
Txns: Disposed/sold 36,324 options to buy @ $5.82, valued at $211.4k
Disposed/sold 58,823 options to buy @ $13.6, valued at $800k
02/24/2023 4 Kalb Michael Wayne (EVP & CFO) has filed a Form 4 on CinCor Pharma, Inc.
Txns: Disposed/sold 202,437 shares @ $0
Disposed/sold 77,615 options to buy @ $30.07, valued at $2.3M
02/24/2023 4 Lee June (Director) has filed a Form 4 on CinCor Pharma, Inc.
Txns: Disposed/sold 47,954 options to buy @ $16, valued at $767.3k
02/24/2023 4 Pearce Catherine (COO) has filed a Form 4 on CinCor Pharma, Inc.
Txns: Unknown transaction of 140,149 shares @ $0
Disposed/sold 15,000 shares @ $0
Unknown transaction of 1,500 shares @ $0
Disposed/sold 110,136 options to buy @ $2.55, valued at $280.8k
Disposed/sold 13,236 restricted stock units @ $0
02/24/2023 4 THERO JOHN F (Director) has filed a Form 4 on CinCor Pharma, Inc.
Txns: Disposed/sold 36,324 options to buy @ $5.82, valued at $211.4k
Disposed/sold 58,823 options to buy @ $13.6, valued at $800k
02/24/2023 4 de Garidel Marc (CEO) has filed a Form 4 on CinCor Pharma, Inc.
Txns: Unknown transaction of 12,500 shares @ $0
Disposed/sold 200,000 shares @ $0
Disposed/sold 726,483 options to buy @ $5.82, valued at $4.2M
Disposed/sold 601,901 options to buy @ $7.62, valued at $4.6M
01/30/2023 4 de Garidel Marc (CEO) has filed a Form 4 on CinCor Pharma, Inc.
Txns: Granted 200,000 shares @ $0
01/30/2023 4 Pearce Catherine (COO) has filed a Form 4 on CinCor Pharma, Inc.
Txns: Granted 15,000 shares @ $0
01/30/2023 4 Kalb Michael Wayne (EVP & CFO) has filed a Form 4 on CinCor Pharma, Inc.
Txns: Granted 177,000 shares @ $0
01/30/2023 4 Freeman Mason (Chief Medical Officer) has filed a Form 4 on CinCor Pharma, Inc.
Txns: Granted 40,000 shares @ $0
01/19/2023 4 Pearce Catherine (COO) has filed a Form 4 on CinCor Pharma, Inc.
Txns: Paid exercise price by delivering 3,997 shares @ $28.75, valued at $114.9k
Exercised 13,235 restricted stock units @ $0
01/10/2023 4 Allison David D. (Director) has filed a Form 4 on CinCor Pharma, Inc.
Txns: Granted 1,499 options to buy @ $11.78, valued at $17.7k
11/08/2022 4 Kalb Michael Wayne (EVP & CFO) has filed a Form 4 on CinCor Pharma, Inc.
Txns: Granted 25,437 shares @ $0
Granted 77,615 options to buy @ $30.07, valued at $2.3M
11/08/2022 3 Kalb Michael Wayne (EVP & CFO) has filed a Form 3 on CinCor Pharma, Inc.
10/12/2022 4 Allison David D. (Director) has filed a Form 4 on CinCor Pharma, Inc.
Txns: Granted 524 options to buy @ $33.49, valued at $17.5k
08/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/08/2022 4 HEALY JAMES (10% Owner) has filed a Form 4 on CinCor Pharma, Inc.
Txns: Exercised 29,411 options to buy @ $13.6, valued at $400k
07/20/2022 4 Allison David D. (Director) has filed a Form 4 on CinCor Pharma, Inc.
Txns: Granted 881 options to buy @ $20.2, valued at $17.8k
07/20/2022 4/A Allison David D. (Director) has filed a Form 4 on CinCor Pharma, Inc.
Txns: Granted 1,038 options to buy @ $19.55, valued at $20.3k
05/11/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/13/2022 4 GENERAL ATLANTIC GENPAR (BERMUDA), L.P. (10% Owner) has filed a Form 4 on CinCor Pharma, Inc.
Txns: Converted 2,426,470 shares @ $0
Bought 1,700,000 shares @ $16, valued at $27.2M
Converted 8,250,000 preferred shares @ $0
01/13/2022 4 GENERAL ATLANTIC, L.P. (10% Owner) has filed a Form 4 on CinCor Pharma, Inc.
Txns: Converted 2,426,470 shares @ $0
Bought 1,700,000 shares @ $16, valued at $27.2M
Converted 8,250,000 preferred shares @ $0
01/13/2022 4 5AM Partners VI, LLC (10% Owner) has filed a Form 4 on CinCor Pharma, Inc.
Txns: Converted 3,683,823 shares @ $0
Converted 183,823 shares @ $0
Bought 157,500 shares @ $16, valued at $2.5M
Bought 312,500 shares @ $16, valued at $5M
Converted 9,999,999 preferred shares @ $0
Converted 2,525,000 preferred shares @ $0
Converted 625,000 preferred shares @ $0
01/13/2022 4 CinRx Pharma, LLC (10% Owner) has filed a Form 4 on CinCor Pharma, Inc.
Txns: Converted 1,222,530 shares @ $0
Converted 2,142,856 preferred shares @ $0
Converted 2,013,749 preferred shares @ $0
01/13/2022 4 Sofinnova Venture Partners X, L.P. (10% Owner) has filed a Form 4 on CinCor Pharma, Inc.
Txns: Converted 5,248,949 shares @ $0
Bought 325,000 shares @ $16, valued at $5.2M
Converted 13,571,428 preferred shares @ $0
Converted 4,275,000 preferred shares @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy